According to the global vaccine delivery devices market research report by IMARC Group, the market reached a value of US$ 7.0 Billion in 2022, and it is projected to reach a value of US$ 10.9 Billion by 2028, exhibiting a CAGR of 7.5% during 2023-2028.
Vaccine delivery devices refer to several engineered instruments that carry the vaccine into or throughout the body. Some of the commonly used products include syringes and jet injectors, and in terms of components, they can be categorized into nanoparticles, liposomes, microspheres, micellar, plant-derived viruses, etc. These vaccine delivery devices allow targeted delivery or control release of the biological substances that are developed to protect individuals from bacterial and virus illnesses by boosting the immune response of the body against the disease. Consequently, they are extensively utilized in hospitals, clinics, and other healthcare establishments across the globe.
The increasing technological advancements and the development of electroporation and micro-needles are among the key factors driving the vaccine delivery devices market. In addition to this, the growing consumer inclination towards using needle-free delivery systems, owing to the reduced risk of needle stick injuries and enhanced vaccine immunogenicity, is further stimulating the market growth.
Request And Get A Sample Brochure For Free: https://www.imarcgroup.com/vaccine delivery devices-market/requestsample
Moreover, the launch of various immunization programs by government bodies across countries aimed at preventing death and disabilities from vaccine-preventable diseases is acting as another significant growth-inducing factor. Apart from this, extensive investments by non-governmental organizations (NGOs) in numerous vaccination programs and campaigns are also positively influencing the global market. Furthermore, the rising focus of key market players on introducing novel techniques that enhance the therapeutic value of vaccines by lowering toxicity, the expanding healthcare industry, and the ease of access to medical products and services are expected to bolster the vaccine delivery devices market over the forecasted period.
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
3M Company, Becton Dickinson and Company, Enesi Pharma Limited, Gerresheimer AG, INOVIO Pharmaceuticals, NanoPass, Panacea Biotec Pharma Limited (Panacea Biotec), Pharmajet Inc., Schott AG (Carl-Zeiss-Stiftung), Terumo Corporation and Vaxxas.
The report has been segmented the market into following categories:
Breakup by Device:
- Jet Injectors
Breakup by Route of Administration:
- Intramuscular Vaccination
- Intradermal Vaccination
- Subcutaneous Vaccination
Breakup by End User:
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan,India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France,United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Ask An Analyst: https://www.imarcgroup.com/request?type=report&id=5933&flag=C
Key Questions Answered in the Global Vaccine Delivery Devices Market Report
• How has the global Vaccine Delivery Devices industry performed in the past and how will it perform in the near future?
• What is the impact of COVID-19 on the global Vaccine Delivery Devices market?
• What are the key regions in the global Vaccine Delivery Devices industry?
• What are the major driving factors and challenges in the global Vaccine Delivery Devices market?
• What is the structure of the global Vaccine Delivery Devices industry and who are the leading players?
• What is the degree of competition in the market?
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 |
Africa and Europe :- +44-702-409-7331 |
Asia: +91-120-433-0800, +91-120-433-0800